1-heterocyclyl-1,5-dihydro-pyrazolo[3,4d] pyrimidin-4-one derivatives and their use as PDE9A modulators

Details for Australian Patent Application No. 2009232017 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Fuchs, Klaus; Heine, Niklas; Fox, Thomas; Schaenzle, Gerhard; Eickmeier, Christian; Giovannini, Riccardo; Fiegen, Dennis; Doerner-Ciossek, Cornelia; Rosenbrock, Holger

Agent Spruson & Ferguson

Pub. Number AU-A-2009232017

PCT Pub. Number WO2009/121919

Priority 08153987.6 02.04.08 EP

Filing date 1 April 2009

Wipo publication date 8 October 2009

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

Event Publications

16 September 2010 PCT application entered the National Phase

  PCT publication WO2009/121919 Priority application(s): WO2009/121919

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009232027-Use of a combination of udenafil and alfuzosin or oxybutynin for the treatment of overactive bladder.

2009232015-Process for manufacturing asphalt